Treatment of Vaginal Candidiasis
For uncomplicated vulvovaginal candidiasis (VVC), the first-line treatment options include topical azole formulations or a single 150 mg oral dose of fluconazole, both of which are equally effective with clinical cure rates of approximately 80% in acute cases. 1, 2
Diagnosis
- Diagnosis is based on:
- Symptoms: pruritus, vaginal discharge, soreness, dyspareunia
- Physical findings: erythema of vagina or vulva, white discharge
- Laboratory: wet preparation or Gram stain showing yeasts/pseudohyphae
- Normal vaginal pH (≤4.5)
- 10% KOH preparation improves visualization of yeast
Treatment Options
Uncomplicated VVC (First Episode or <4 Episodes/Year)
Topical Azole Options:
- Clotrimazole 1% cream: 5g intravaginally for 7-14 days 1
- Clotrimazole 2% cream: 5g intravaginally for 3 days 1
- Miconazole 2% cream: 5g intravaginally for 7 days 1
- Miconazole 4% cream: 5g intravaginally for 3 days 1
- Miconazole 100mg vaginal suppository: One daily for 7 days 1
- Miconazole 200mg vaginal suppository: One daily for 3 days 1
- Miconazole 1200mg vaginal suppository: Single application 1
- Tioconazole 6.5% ointment: 5g intravaginally as single application 1
- Terconazole 0.4% cream: 5g intravaginally for 7 days 1
- Terconazole 0.8% cream: 5g intravaginally for 3 days 1
- Terconazole 80mg suppository: One daily for 3 days 1
- Butoconazole 2% cream: 5g intravaginally for 3 days or single-dose bioadhesive product 1
Oral Option:
Complicated VVC (Severe Symptoms, Non-albicans Species, or Recurrent VVC)
Recurrent VVC (≥4 Episodes/Year):
- Initial treatment: 7-14 days of topical therapy or multiple doses of oral fluconazole 2
- Maintenance therapy: Fluconazole 150mg weekly for 6 months 2
Alternative Treatments for Resistant Cases:
- Boric acid: 600mg intravaginal capsule daily for 14 days 2
- Nystatin: 100,000 units intravaginal suppository daily for 14 days 2
Special Populations
Pregnancy
HIV Infection
- Same treatment as for non-HIV infected patients 1
Treatment Efficacy and Follow-up
- Topical azoles and oral fluconazole have similar efficacy with 80-90% clinical cure rates 1, 4
- No routine follow-up needed if symptoms resolve 2
- Reevaluation necessary if symptoms persist after treatment 2
Common Pitfalls to Avoid
- Misdiagnosis: Less than half of patients treated for VVC are diagnosed with an objective test 1
- Self-treatment limitations: Self-medication with OTC preparations should only be advised for women previously diagnosed with VVC experiencing recurrence of the same symptoms 1
- Persistent symptoms: May indicate non-albicans Candida species requiring alternative treatment 2, 5
- Overuse of fluconazole: Can lead to development of resistant strains, especially with non-albicans species 5
Treatment Algorithm
Assess severity and history:
- First episode or <4 episodes/year = uncomplicated
- Severe symptoms, non-albicans species, or ≥4 episodes/year = complicated
For uncomplicated VVC:
- Choose either topical azole (1-7 days) or single-dose oral fluconazole 150mg
- Patient preference may guide choice (convenience vs. gastrointestinal side effects)
For complicated VVC:
- Extend treatment duration (7-14 days for topical or multiple doses of fluconazole)
- Consider maintenance therapy for recurrent cases
- For resistant cases, consider boric acid or nystatin
If treatment fails:
- Confirm diagnosis with culture
- Consider non-albicans species and adjust treatment accordingly